Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa

Overview of attention for article published in Open Forum Infectious Diseases, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 21 X users

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 26 X posts from 21 X users, with an upper bound of 102,928 followers.

RT @IDpharmresearch: Congratulations to Sara Alosaimy and all co-authors on the real-world meropenem-vaborbactam observational study public…

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa https://t.co/ijvMpNHRI7

RT @accpinfdprn: New in OFID 📣📣 Real-world, Multi-Center Experience with Meropenem-Vaborbactam. A collaboration between many @ACCP @SIDPhar…

https://t.co/prmbwF0ZDL https://t.co/8Z74W0rFBj

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 22 additional X posts.